n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, DB; Coupal, JJ; Dekosky, ST; Kung, HF; Pulmano, C; Ryo, UY; Shih, WJ; Simmons, G | 1 |
| Brittain, HM; Demyer, MK; Farlow, MR; Hall, KS; Hendrie, HC; Wellman, HN | 1 |
2 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
I-123 hydroxyiodobenzyl propanediamine (HIPDM) cerebral blood flow imaging demonstrating transtentorial diaschisis.
Topics: Alzheimer Disease; Brain; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Iodine Radioisotopes; Iodobenzenes; Tomography, Emission-Computed, Single-Photon | 1990 |
Single photon emission tomographic brain images in dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Humans; Iodobenzenes; Middle Aged; Tomography, Emission-Computed | 1987 |